Ser4029

Site Information
AMBIGUOUS SITES: EPPK1 (human): , EPPK1 (human): , EPPK1 (human): , EPPK1 (human):
GsAVHQLsEELRCAL SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 27448313

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 3 )
Disease tissue studied:	luminal A breast cancer ( 1 ) , breast cancer, surrounding tissue ( 1 ) , lung cancer ( 3 ) , non-small cell lung adenocarcinoma ( 3 )
Relevant cell line - cell type - tissue:	breast ( 1 ) , lung ( 3 )

References
1	Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62 27251275 Curated Info
2	Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704 24719451 Curated Info
3	Schweppe DK, Rigas JR, Gerber SA (2013) Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 91, 286-96 23911959 Curated Info
4	Shiromizu T, et al. (2013) Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res 12, 2414-21 23312004 Curated Info